BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20814143)

  • 1. Posterior reversible encephalopathy syndrome.
    Akl KF; Samara OA
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):957-8. PubMed ID: 20814143
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome.
    Ishikura K; Ikeda M; Hamasaki Y; Hataya H; Nishimura G; Hiramoto R; Honda M
    Nephrol Dial Transplant; 2008 Aug; 23(8):2531-6. PubMed ID: 18258739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin-A induced posterior reversible encephalopathy syndrome.
    Saeed B; Abou-Zor N; Amer Z; Kanani I; Hilal M
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):439-42. PubMed ID: 18445907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine treatment of nephrotic syndrome in children.
    Brodehl J; Hoyer PF; Oemar BS; Helmchen U; Wonigeit K
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):269-74. PubMed ID: 3381282
    [No Abstract]   [Full Text] [Related]  

  • 5. Focal segmental glomerulosclerosis in children complicated by posterior reversible encephalopathy syndrome.
    Stârcea M; Gavrilovici C; Munteanu M; Miron I
    J Int Med Res; 2018 Mar; 46(3):1172-1177. PubMed ID: 29310486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A-induced posterior reversible encephalopathy syndrome in an adolescent with steroid-resistant nephrotic syndrome.
    Hacihamdioğlu DÖ; Gökhan A; Cihan M; Mul K; Ferhan K; Süleymanoğlu S
    Int Urol Nephrol; 2014 Oct; 46(10):2055-6. PubMed ID: 24908282
    [No Abstract]   [Full Text] [Related]  

  • 7. Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis.
    de Oliveira RA; Fechine LM; Neto FC; Nicodemus JM; Silva GB; Silva LS
    Int Urol Nephrol; 2008; 40(4):1095-8. PubMed ID: 18661248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine in nephrotic syndrome.
    Ponticelli C; Rivolta E
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):253-8. PubMed ID: 3289208
    [No Abstract]   [Full Text] [Related]  

  • 10. Two patients with focal segmental glomerulosclerosis complicated by cyclosporine-induced reversible posterior leukoencephalopathy syndrome.
    Sakai N; Kawasaki Y; Imaizumi T; Kanno S; Go H; Mitomo M; Ushijima Y; Suyama K; Ito M; Hashimoto K; Hosoya M
    Clin Nephrol; 2010 Jun; 73(6):482-6. PubMed ID: 20497762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia-associated nephrotic syndrome caused by focal segmental glomerulosclerosis.
    Rosado MF; Morgensztern D; Abdullah S; Ruiz P; Lossos IS
    Am J Hematol; 2004 Oct; 77(2):205-6. PubMed ID: 15389914
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible posterior leukoencephalopathy syndrome in a patient of FSGS with heavy proteinuria.
    Nabi Z; Al Korbi L; Ghailani M; Nadri Q; Abdelsalam M; Al Baqumi M
    Ren Fail; 2010; 32(7):892-4. PubMed ID: 20662706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin treatment of recurrent nephrotic syndrome and focal segmental glomerulosclerosis after renal transplantation.
    Kooijmans-Coutinho MF; Tegzess AM; Bruijn JA; Florijn KW; van Es LA; van der Woude FJ
    Nephrol Dial Transplant; 1993; 8(5):469-73. PubMed ID: 8393556
    [No Abstract]   [Full Text] [Related]  

  • 14. Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient.
    Bodmer M; Amico P; Mihatsch MJ; Haschke M; Kummer O; Krähenbühl S; Mayr M
    Nephrol Dial Transplant; 2007 Aug; 22(8):2366-70. PubMed ID: 17526544
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid-responsive focal segmental glomerulosclerosis in primary antiphospholipid syndrome with successful pregnancy outcome.
    Bhowmik D; Dadhwal V; Dinda AK; Handa R; Dash SC
    Nephrol Dial Transplant; 2005 Aug; 20(8):1726-8. PubMed ID: 15919690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cyclosporine in the treatment of primary focal-segmental glomerulosclerosis].
    Pavlović S; Djukanović Lj; Sindjić M; Stojković D; Banković-Calić N; Velimirović D
    Srp Arh Celok Lek; 1996; 124 Suppl 1():51-3. PubMed ID: 9102929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal and segmental glomerulosclerosis (FSGS). Clinical, morphological and genetic features.
    Gusmano R; Mazzucco G; Monga G; Ghiggeri GM
    J Nephrol; 2004; 17(1):139-57. PubMed ID: 15151272
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary nephrotic syndromes in children in Iran].
    Bodaghi E; Chamsa AM
    Ann Pediatr (Paris); 1978 Jan; 25(1):61-70. PubMed ID: 16114307
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapse of nephrotic syndrome following remission for 20 years.
    Cuoghi D; Vangelista A; Baraldi A; Cheli E
    Int J Pediatr Nephrol; 1983 Sep; 4(3):211-4. PubMed ID: 6315615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of nephrotic syndrome in focal segmental glomerulosclerosis after transplantation.
    Itami N; Akutus Y; Hattori M; Itoh K
    Pediatr Nephrol; 1990 May; 4(3):298-9. PubMed ID: 2400660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.